Project Details
Description
A Single-arm, Phase 2 Study to Evaluate the Safety and Efficacy of VT-464 in Patients with Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone prostate cancer progressing on enzalutamide or abiraterone
Status | Finished |
---|---|
Effective start/end date | 9/1/15 → 4/30/19 |
Funding
- INNOCRIN PHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.